PRESS RELEASE published on 10/16/2024 at 11:55, 1 month 6 days ago APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary public purchase offer APONTIS PHARMA partners with Zentiva for growth, offering shareholders EUR 10.00 per share in a voluntary public purchase offer. Zentiva aims for majority stake and strategic collaboration Partnership Growth APONTIS PHARMA Voluntary Offer Zentiva
PRESS RELEASE published on 10/16/2024 at 11:50, 1 month 6 days ago EQS-Adhoc: APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer APONTIS PHARMA and Zentiva enter into investment agreement for voluntary public purchase offer at EUR 10.00 per share in cash. Zentiva aims to support future growth of APONTIS PHARMA APONTIS PHARMA Investment Agreement Voluntary Purchase Offer Zentiva EUR 10.00
BRIEF published on 10/08/2024 at 13:05, 1 month 14 days ago EV Nickel Discovers New High-Grade Nickel Zones Extending Carlang Trend Diamond Drill Program Nickel Exploration Mineralization Zones High-grade Nickel Carlang Trend Expansion
PRESS RELEASE published on 10/08/2024 at 13:00, 1 month 14 days ago EV Nickel Intersects 3 New Zones of Mineralization on the Carlang Trend Including Highest Nickel Grades to Date & Significantly Extends Strike Length by 7km EV Nickel Inc. announces successful diamond drill program on CarLang Trend confirming near surface nickel mineralization and identifying 3 new zones of large-scale mineralization over 7km of strike Diamond Drill Program EV Nickel Inc. Nickel Mineralization CarLang Trend Large-scale Mineralization
BRIEF published on 09/04/2024 at 13:05, 2 months 18 days ago EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11% Exploration Nickel Assay Results High-grade Langmuir #2
PRESS RELEASE published on 09/04/2024 at 13:00, 2 months 18 days ago EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11% EV Nickel Inc. reports high-grade nickel intercepts including 5.11% Ni in Langmuir #2 Nickel Zone, with assay results indicating high nickel tenor. Company plans further drilling to advance Canadian nickel supply chain Drilling Program Assay Results EV Nickel Inc. High-grade Nickel Canadian Nickel Supply Chain
BRIEF published on 08/16/2024 at 10:46, 3 months 6 days ago First Berlin Equity Research Reaffirms BUY Rating for APONTIS PHARMA AG First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Single Pill Business
PRESS RELEASE published on 08/16/2024 at 10:41, 3 months 6 days ago Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research recommends buying APONTIS PHARMA AG shares with a target price of €17 after solid H1/24 results and positive outlook. Analyst Christian Orquera maintains his BUY rating First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Christian Orquera
BRIEF published on 08/09/2024 at 07:35, 3 months 14 days ago APONTIS PHARMA Reports Strong Half-Year Growth in 2024 Revenue Growth APONTIS PHARMA Single Pill Combinations EBITDA Improvement Novartis Cooperation
PRESS RELEASE published on 08/09/2024 at 07:30, 3 months 14 days ago APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of 2024 – forecast for the full year confirmed APONTIS PHARMA reports profitable revenue growth with Single Pill combinations in the first half of 2024. Forecast for full year 2024 confirmed. Earnings and sales improvements noted EBITDA Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations
Published on 11/22/2024 at 23:55, 9 hours 10 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 35 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 35 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 50 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 11 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 9 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 5 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024